Cytokine Pattern Secretion by Murine Spleen Cells After Inactivated Candida Albicans Immunization. Effect of Cocaine and Morphine Treatment

References

• Vecchiarelli A., Cenci E., Puliti M., Blasi E., Puccetti P., Cassone A., Bistoni F. Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state. Cell. Immunol. 1989; 124: 334
   PubMedGoogle Scholar
• Scaringi L., Cornacchione P., Rosati E., Boccanera M., Cassone A., Bistoni F., Marconi P. Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans. Cell. Immunol. 1990; 129: 271
   PubMedGoogle Scholar
• Wang Y., Li S. P., Moser S. A., Bost K. L., Domer J. E. Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan. Infect. Immun. 1998; 66: 1384
   Google Scholar
• Fresno M., Kopf M., Rivas L. Cytokines and infectious diseases. Immunol. Today 1997; 18: 56
   PubMedGoogle Scholar
• O'Garra A., Murphy K. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 1994; 6: 458
   PubMed Web of Science ®Google Scholar
• Fischer E. G. Opioid peptides modulate immune functions. A review. Immunopharmacol. Immunotoxicol. 1988; 10(3)265
   PubMed Web of Science ®Google Scholar
• Di Francesco P., Gaziano R., Casalinuovo I. A., Belogi L., Palamara A. T., Favalli C., Garaci E. Combined effect of fluconazole and thymosin α1 on systemic candidiasis in mice immunosuppressed by morphine treatments. Clin. Exp. Immunol. 1994; 97: 347
   PubMed Web of Science ®Google Scholar
• Di Francesco P., Falchetti R., Gaziano R., Lanzilli G., Belogi L., Ravagnan G., Garaci E. Differential effects of short-term or prolonged cocaine exposure on peripheral blood cells in mice. Life Sci. 1994; 54: 2015
   PubMed Web of Science ®Google Scholar
• Peterson P. K., Molitor T. W., Chao C. C. Mechanism of morphine-induced immunomodulation. Biochem. Pharmacol. 1993; 46: 343
   PubMedGoogle Scholar
• Watzl B., Watson R. R. Immunomodulatory by cocaine-a neuroendocrine mediated response. Life Sci. 1990; 46: 1319
   PubMed Web of Science ®Google Scholar
• Bistoni F., Vecchiarelli A., Cenci E., Puccetti P., Marconi P., Cassone A. Evidence of macrophage-mediated protection against lethal Candida albicans infection. Infect. Immun. 1986; 51: 668
   PubMed Web of Science ®Google Scholar
• Càrdenas-Freytag L., Cheng E., Mayeux P., Domer J. E., Clements J. D. Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis. Infect. Immun. 1999; 67: 826
   PubMed Web of Science ®Google Scholar
• Kelso A. Th1 and Th2 subsets: paradigms lost?. Immunol. Today 1995; 16: 374
   PubMedGoogle Scholar
• Di Francesco P., Marini S., Pica F., Favalli C., Tubaro E., Garaci E. In vivo cocaine administration influences lymphokine production and humoral immune response. Immunol. Res. 1992; 11: 74
   PubMedGoogle Scholar
• Wang Y., Huang D. S., Giger P. T., Watson R. R. The influence of cocaine in vivo and in vitro production of cytokines by Thl and Th2 cells. Adv. Biosci. 1993; 86: 673
   Google Scholar
• Chen G., Watson R. R. Modulation of tumor necrosis factor and gamma-interferon production by cocaine and morphine in aging mice infected with LP-BM5, a murine retrovirus. J. Leukocyte Biol. 1991; 50: 349
   PubMedGoogle Scholar
• Wang Y., Huang D. S., Watson R. R. In vivo and in vitro cocaine modulation on production of cytokines in C57BL/6 mice. Life Sci. 1994; 54: 401
   PubMedGoogle Scholar
• Carr D. J. J., Serou M. Exogenous and endogenous opioids as biological response modifiers. Immunopharmacology 1995; 31: 59
   PubMedGoogle Scholar
• Torres G., Rivier C. Differential effects of intermittent or continous exposure to cocaine on the hypotalamic-pituitary-adrenal axis and c-fos expression. Brain Res. 1992; 571: 204
   PubMedGoogle Scholar
• Mosmann T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 1996; 17: 138
   PubMedGoogle Scholar
• Falchetti R., Di Francesco P., Lanzilli G., Gaziano R., Casalinuovo I. A., Palamara A. T., Ravagnan G., Garaci E. Determination of cytokine co-expression in individual splenic CD4+ and CD8+ T cells from influenza virus-immune mice. Immunology 1998; 95: 346
   PubMed Web of Science ®Google Scholar
• Nelson C. J., Dykstra L. A., Lysle D. T. Comparison of the time course of morphine's analgesic and immunologic effects. Anesth. Anal. 1997; 85: 620
   PubMed Web of Science ®Google Scholar
• Sheng W. S., Hu S., Gekker G., Zhu S., Peterson P. K., Chao C. C. Immunomodulatory role of opioids in the central nervous system. Arch. Immunol. Ther. Exp. 1997; 45: 359
   PubMedGoogle Scholar
• Bayer B. M., Daussin S., Hernandez M., Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 1990; 29: 369
   PubMedGoogle Scholar